<unk>  has not been shown to have an increased incidence in any specific country or ethnic group. In the United States, the incidence of affected males is estimated at 1:21,000. Overall incidence of hemizygous males and carrier females is estimated at 1:16,800. The reported incidence in France is estimated at 1:22,000.
Adrenoleukodystrophy
Hereditary inclusion body myopathy
Inclusion body myositis
Mitochondrial myopathy
Familial amyloid neuropathy
Familial amyloid polyneuropathy
Charcot–Marie–Tooth disease
Lambert–Eaton myasthenic syndrome